Brief: Spectracure Gets Approval To Commence Clinical Trial
Oct 8 (Reuters) - SpectraCure AB (publ) SPEC.ST: RECEIVES FINAL APPROVAL FROM GERMAN AUTHORITIES TO COMMENCE CLINICAL TRIAL Source text: ID:nMFN2d6bpq Further company coverage: SPEC.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))